Ardent Health, Inc. (ARDT): debt financing — Ardent Health amends $777.5M term loan facility; rate cut 50 bps, maturity extended to 2032

Ardent Health, Inc.

Interest rate reduced by 50 bps to Term SOFR + 2.25%; expected annual interest savings of ~$3.9M.
Maturity extended from August 2028 to September 2032, enhancing financial flexibility.
ABL credit agreement also amended to align covenant baskets; no material changes or maturity extension.
CFO Alfred Lumsdaine cites continued confidence of lending partners and support for growth strategy.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Ardent Health, Inc. amended term loan with Bank of America, N.A. at Term SOFR plus 2.25% from Term SOFR plus 2.75% maturing September 18, 2032.

Instrument: term loan
Counterparty: Bank of America, N.A.
Rate: Term SOFR plus 2.25% from Term SOFR plus 2.75%
Maturity: September 18, 2032
Event: amendment

Exact text from the filing

extend the maturity date for the term loans from August 24, 2028 to September 18, 2032, (iii) reduce the applicable interest rate by 50 basis points from Term Secured Overnight Financing Rate (“SOFR”) plus 2.75% to Term SOFR plus 2.25%

View on SEC.gov

103 debt financings filed in the last 30 days. Browse all debt financings →

Ardent Health, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-25-042486

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.